Contents:

BLOOD BANKING & BLOOD PRODUCTS A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3 Blood Components and Plasma Products I-3 Whole Blood & Cellular Components I-3 WBCs I-4 RBCs I-4 Platelets I-4 Plasma Fractions I-4 Fresh Frozen Plasma I-4 Albumin Fractions I-4 Factor VIII I-4 Factor IX and Factor IX Complex I-5 Fibrin/Thrombin I-5 Equipment, Blood Tests and Consumables I-5 Automated Analyzers for Blood Analysis I-5 Blood Tests I-5 Consumables I-5 II. Executive Summary 1. Market Overview II-1 Healthcare Scares Propel the Market II-1 Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts II-1 Worldwide Blood Banking and Blood Products Market at a Glance II-2 Current & Future Analysis II-2 Analysis by Geographic Region II-2 Analysis by Product Segment II-3 World Blood Components and Plasma Market Analysis in Units II-3 Table 1: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart) II-3 Table 2: World 10-Year Perspective for Blood Components and Plasma by Region/Country - Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart) II-4 Red Blood Cells - A Key Blood Component and a Major Contributor II-5 Table 3: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country - USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart) II-5 Table 4: World 10-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart) II-5 2. Market Trends & Issues II-6 New Infections - A Continuous Threat II-6 Safety and Availability: The Core Issues II-6 Decontamination: A Viable Process II-7 New Processes for Safer Blood Supply II-7 Innovative Procedures Help Blood Conservation II-7 Autologous Transfusion Strapping up for High Growth II-7 Enzyme Converted Cells Set to Rule the Industry II-7 Blood Unavailability: Substitutes to the Rescue II-8 Transfusions: Hospitals Making Way for Others II-8 Computer Identification Helps Patients II-8 SARS: A Case of Mistaken Identity? II-9 Pooling: Economical HIV Testing II-9 Private Cord Blood Banking: Flying High Despite Opposition II-9 Consolidation Whittles Down Number of Market Players II-9 Table 5: Leading Players in World Market for Plasma Fractionation (2005): Percentage Breakdown of Fractionation Capacity for CSL Limited, Telecris, Baxter, Grifols, Octapharma and Others (includes corresponding Graph/Chart) II-10 Automation of Blood Banking - Nearing the Efficiency Frontier? II-10 Automated Instrumentation Taking the Front Seat II-10 Table 6: World Market for Blood Bank Technology (2004): Percentage Breakdown of Revenues by Segment - Manual Blood Bag Systems, Automated Systems, Component Lab, Commercial Plasma, Blood Salvage, and Pathogen Inactivation (includes corresponding Graph/Chart) II-10 Table 7: Leading Players in the World Market for Automated Collection of Blood Components using Apheresis Technology (2005): Percentage Breakdown of Revenues for Gambro, Baxter, Haemonetics, Fresenius, and Others (includes corresponding Graph/Chart) II-11 Plasma Market: Automation Making Inroads II-11 The RBC Market - Slow to Catch Up II-11 Automation of Testing - Yet to Mature II-11 Automation to Suffice Shortage Problems II-12 How Near to the Efficiency Frontier? II-12 3. Product Overview II-13 Blood Banking and Blood Products Industry II-13 Blood Components and Plasma Products II-13 Equipment, Blood Tests and Consumables II-13 Automated Analyzers for Blood Analysis II-13 Blood Tests II-13 Consumables II-14 Blood Collection Equipment II-14 Blood Collection Monitors II-14 Blood Donor Couches II-14 Blood Processing Equipment II-14 Blood Bank Centrifuges II-14 Plasma Thawing II-14 Blood Cell Separators II-14 Blood Storage Equipment II-15 Blood Bags II-15 Platelet Agitators II-15 Blood Bank Refrigerators II-15 Blood - A Primer II-15 Ionic Structure II-15 Blood Components and their Applications II-16 Blood Constituents II-17 Plasma II-17 Red Blood Cells (RBC) II-17 Blood Count II-18 Platelets II-18 Table 8: Platelets (Leucodepleted) Issued by Select Region/ Agency (2005) (includes corresponding Graph/Chart) II-18 White Blood Cells (WBC) II-19 Derivative Products of Blood or Plasma Fractions II-19 Plasma Protein and Fractionation II-19 The Need II-19 Fresh Frozen Plasma II-20 Other Plasma Fractions II-20 Albumin Fractions II-20 Albumin Usage Rising in Profile, Wastage Worries Run Deep II-20 Immunoglobulins II-20 Table 9: Leading Countries in IVIg Usage Rates in Grams per 1000 Population (includes corresponding Graph/Chart) II-21 Hyper-Immune Immunoglobulin II-21 Factor VIII II-21 Table 10: Leading Players in World Market for Factor VIII (2006): Percentage Breakdown of Revenues for Baxter, Bayer (Kogenate), CSL Behring (Helixate) and Wyeth (includes corresponding Graph/Chart) II-21 Factor IX and Factor IX Complex II-21 Fibrin/Thrombin II-22 Consumption of Blood Based on Type of Surgery/ Accident (In Units) II-22 Table 11: World Market for Plasma Derivatives (2005): Percentage Breakdown of Revenues by Region/Country - USA, Europe, Asia-Pacific, Latin America, and Rest of World (includes corresponding Graph/Chart) II-22 Table 12: World Market for Plasma Derivatives (2006): Percentage Breakdown of Revenues by Product Type - IVIg, Factor VIII, Albumin, Hyperimmunes, Factor IX and Others (includes corresponding Graph/Chart) II-22 Table 13: Plasma Collection in Select Countries in Thousand Liters (2005) (includes corresponding Graph/Chart) II-23 Recombinant Products II-23 Therapeutic Uses of Plasma Products II-23 Albumin Products II-23 Immunoglobulins II-24 Intravenous Immunoglobulin (IVIg) II-24 Normal Immunoglobulin (IMIg) II-24 CMV Immunoglobulin II-24 Hepatitis B Immunoglobulin II-24 Rh(D) Immunoglobulin II-24 Tetanus Immunoglobulin IM II-24 Zoster Immunoglobulin II-25 Plasma Derived Coagulant Products II-25 Biostate® II-25 Ceprotin® II-25 Factor VII Concentrate II-25 Factor XI Concentrates II-25 Feiba VH® Inhibitor Treatment II-25 Fibrogammin P® II-25 Monofix®-VF II-25 ProthrombinexTM-HT II-26 Thrombotrol®-VF II-26 4. Blood Collection Methods II-27 Banking the Natural Blood Resources II-27 Blood Banks II-27 Blood Banking II-27 Blood Transfusion II-27 Role of Blood Banks II-27 Blood Donor: The Epicenter of the Process II-27 Eligibility Criteria for the Donor II-28 The Basics of Blood Donation - Myths Exploded & Other Facts II-28 Table 14: Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/Agency (2004 & 2005) (includes corresponding Graph/Chart) II-29 Table 15: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (2005) (includes corresponding Graph/Chart) II-30 Collection Methods II-30 Blood Donation: The Process II-30 Types of Blood Donation II-30 Directed Blood Donations II-30 Autologous Blood Donation II-31 Alternative Usage of Patient’s Own Blood II-31 General Blood Donation II-31 Hemodilution II-31 Wound Drainage II-31 Cell Saver II-31 The Method II-31 Blood Salvaging II-32 Blood Collection Centers II-32 Blood Collection Management System II-32 A Historical Retrospective II-32 Blood Collection Centers II-32 Types of Blood Collection Centers II-32 Cord Blood Banks II-32 Profit Collection Centers II-33 Military Blood Banks II-33 Hospital Blood Banks II-33 Community Blood Banks II-33 Non-Profit Collection Centers II-33 Blood Processing II-34 Blood Typing II-34 Rh Blood Group System II-35 ABO Blood Group System II-35 Blood Types and their Compatibility II-35 Table 16: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart) II-36 Blood Test II-36 Blood Culture II-36 The Costs II-36 History of Blood Banking II-37 5. The Changing Landscape of Transfusion Technologies & Tests II-39 Blood Transfusion: A Backdrop II-39 Massive Transfusion II-39 Complications and Risks Due to Transfusion II-39 Circulatory Overload II-40 Graft Versus Host Disease (GVHD) II-40 Haemolytic Transfusion Reactions II-40 Iron Overload II-40 Bacterial Contamination II-40 Thrombophlebitis II-40 Allergic Reactions II-40 Air Embolism II-41 Hyperkalaemia II-41 Changing Role of Blood Banking Technology II-41 6. Blood Transfusion: The Process, Tests/Technologies II-42 Cross Matching II-42 Blood Donor/Recipient Screening II-42 Blood Typing II-42 Leukoreduction II-42 Leukocyte Reduction Specification Standards/Filters II-43 Coombs Test II-43 7. Alternatives to Blood Transfusion: A Real Threat to the Industry II-44 Bloodless Surgery II-44 Therapeutic Apheresis II-44 Plasmapheresis II-44 Plateletpheresis II-44 Leukapheresis II-45 Volume Expanders II-45 Colloids II-45 Albumin II-45 Dextrans II-45 Hydroxyethyl Starch II-45 Crystalloids II-45 Blood Growth Factor Therapies - Newer Alternatives to Transfusion II-46 8. Blood Substitutes II-47 Blood Substitutes Under Development by Manufacturers II-47 Synthetic Blood Manufacturers/Developers II-48 Alliance Pharmaceuticals Corp. (USA) II-48 Biopure Corporation (USA) II-48 Enzon Pharmaceuticals (USA) II-48 Hemosol Inc. (Canada) II-49 Northfield Laboratories Inc. (USA) II-49 Synthetic Blood International, Inc. (USA) II-49 9. Product Introductions/Innovations II-50 Gen-Probe Introduces APTIMA® HPV Assay II-50 Olympus AU680® Analyzer Offers an Automated HbA1c Assay II-50 Haemonetics Unveils New Plasma Collection Software II-50 Pall Unveils Acrodose™ PLus System II-50 Z-Medica Rolls Out Rapid Blood Clotting Products in the Consumer Market II-51 Dade Behring Launches the Quadriga BeFree System II-51 Swedish Inventors Develop New Processing System II-51 Canada Invents New Method for Monitoring Blood and Blood Products II-51 Terumo Launches Improvised Bags For Safe Blood Collection II-51 Haemonetics Launches Cymbal Automated Blood Collection System II-52 Illinois Inventors Introduces New Systems to Prepare Blood Products II-52 Abbott Unveils Two New Products for Blood Banks II-52 Cell Robotics Introduces New Lasette P 200 II-53 Beckman’s COULTER® LH 750 Hematology Analyzers Hit the Market II-53 Haemonetics Unveils MCS®+ - Improved Red Cell Collection Technology II-53 Baxter Launches ALYX Component Collection System II-53 Grifols’ DG Gel® Revolutionizes Column Agglutination II-54 BioMérieux Introduces DAVINCI® II-54 Pall Develops Novel Blood Filtration Membrane II-54 10. Products in Pipeline & Technology Update II-55 From Clinical Trials to Clinics II-55 Cerus Receives CE Mark Approval for the Intercept Blood System for Platelets II-55 Haemonetics Wins FDA Approval for the ACP 215 System II-55 Biomerieux’ Polycarbonate BacT/ALERT Receives US FDA Clearance II-55 Pall’s eBDS Receives Green Signal from FDA II-56 CardioPAT™ Surgical Blood Salvage System II-56 PCS® 2 - Set to Enhance Plasma Quality II-56 Dade Behring’s D-Dimer Assay Strapping up for Roll Out II-56 11. Recent Industry Activity II-57 Global Med Technologies® Acquires eDonor® II-57 Immucor Snaps Up BioArray Solutions II-57 Global Med Technologies Acquires Inlog II-57 Gen-Probe to Acquire Innogenetics II-57 ProMetic to Hold Major Share in Pathogen Removal and Diagnostic Technologies II-58 ThermoGenesis Partners with GE Healthcare II-58 ThermoGenesis Ties Up with University of California II-58 Gambro Inks Preliminary Agreement with S.C.M S.r.l. II-58 ITL Extends Agreement with American Red Cross II-58 CSL Enters into Agreements with Héma-Québec and Canadian Blood Services II-58 Gambro Launches Bloodline Manufacturing Plant in Czech Republic II-59 Global Med Technologies® and Mid Coast Sign a License Agreement II-59 Global Med Technologies® Inks an Agreement with FBC II-59 ZymoGenetics Obtains FDA Approval for Marketing Recothrom II-60 CellaVision Enters into a Two-Year Manufacturing Agreement with Kitron AB II-60 VITA 34 and BKK Gruner + Jahr Sign Cooperation Agreement II-60 Haemonetics Bags FDA Clearance for eLynx II-60 Haemonetics Obtains FDA Approval for Symphony 2.0 Software II-60 Thermogenesis Receives CE Mark Approval for Marrowxpress™ II-61 Olympus PK 7300® Automated Microplate System Bags FDA Clearance II-61 ABL80 FLEX CO-OX Blood Gas Analyzer Receives FDA Clearance II-61 PK® Blood Grouping and Phenotyping Reagents Get FDA Approval II-61 Blood Banks with quality Transfusion Therapy to Come Up in Indian Metros II-62 Haemonetics Acquires Infonalé II-62 Gambro BCT Changes its Name to Caridian BCT II-62 Terumo Acquires Salymed II-62 Fresenius Takes Over Renal Solutions II-62 PerkinElmer Completes ViaCell Acquisition II-62 Texas Cord Blood Bank Expands Cord Blood Collection Network II-63 Inverness Medical Acquires HemoSense II-63 Haemonetics Acquires Haemoscope’ Hemostasis Analyzer Business Unit II-63 NxStage Medical Completes Medisystems Acquisition II-63 CordLife Establishes Cord Blood Bank in Indonesia II-64 Xinjiang Deyuan Begins Construction of a New Blood Product Plant II-64 Cord Blood America Acquires Curesource II-64 Grifols and Cerus Join Hands to Commercialize Cerus’ Intercept Blood System II-64 Fresenius Kabi Signs Agreement to Acquire Kyorin Pharmaceutical II-64 Immucor and American Red Cross Ink Supply Agreement II-65 Haemonetics Signs Contract with Octapharma II-65 SFDA Revokes Drug Approval and Production Permit of Guangdong Bioyee II-65 Immucor Obtains Clearance from FDA for Marketing Galileo Echo II-65 Novartis Receives Approval for PROCLEIX® TIGRIS® System II-65 Thermogenesis Obtains FDA Approval for Autoxpress™ II-65 CSL Receives Approval for Rhophylac® II-66 CSL Expands Haemate® P Business II-66 ViaCell to Expand ViaCord Processing Laboratory II-66 Cryobanks to Set Up a Cord Blood Bank in Thailand II-66 Grifols to Manage Four New Plasma Collection Centers in US II-66 Hualan Biological Acquires Chongqing Yituo II-66 CyGenics to Focus on Cord Blood Banking II-67 Cord Blood America Acquires CorCell II-67 Stemcyte to Establish Cord Blood Bank in India II-67 Baxter Divests Transfusion Therapies Business II-67 Cerus Obtains Approval for Intercept Blood System in Germany II-68 Cangene Obtains Health Canada Approval for Anti-Hepatitis B Blood Product II-68 Cord Blood America Inks Marketing Agreement with MSBCBS II-68 BCCL Acquires Stake in Life Cell II-68 bioMérieux and AdvanDx Sign Distribution Agreement for Rapid Diagnostic Tests II-68 Vita 34 International AG Expands Umbilical Cord Blood Banking Services II-69 Data Innovations to Develop Data Capture and Reporting System for Fenwal II-69 SunTech Medical Group Acquires Empirical Technologies II-69 Cord Blood America Acquires Cryobank II-69 Kalbe Acquires Stake in CyGenics’s Subsidiary CordLife Indonesia II-70 Cryobanks International Signs Letters of Intent with MedStem Services II-70 Cryobanks International Opens Cord Blood Stem Cell Bank II-70 DomaniCell Initiates Family Cord Blood Banking Program in Hospitals II-70 Cryobanks International Grants License for Cord Blood Processing System II-71 Community Blood Center Bags Contract II-71 Wilkes Medical Center Grants License for SafeTrace Tx II-71 Biosite Collaborates with HUG Research Hospital II-71 Pliva Terminates Agreement with Mayne II-71 Mississippi Blood Services Secures Contract II-72 APL Partners with Omscan II-72 DomaniCell Receives Stem Cell Banking License II-72 ThermoGenesis Enters into an Agreement with Cord Blood Registry II-72 ZLB Enters into Plasma Deal with BCA II-72 ViaCell and Pall Secure FDA Approval for ViaCord® Collection Kit II-73 Pall Secures Contract from NBS to Supply ‘Leukotrap’ Filtration System II-73 Biotest and Sanquin to Form Joint Venture for Plasma Production II-73 Consorta Signs Partnership Agreement with GSABC II-74 Haemonetics Signs Supply Agreement with Canadian Blood Services II-74 Haemonetics Extends the Agreement with American Red Cross II-74 Novation and Abbott Enter into a Technology Agreement II-75 Olympus Redefines the Agreement with Biotest II-75 Cerus to Receive Marketing Rights over Baxter’s INTERCEPT Blood System II-75 CyGenics to Establish a New Cord Blood Banking Company II-76 UKCBB to Establish a Modern Laboratory in UMIC’s New CTF II-76 St. John’s Medical Center Procures Wyndgate’s SafeTrace Tx II-76 Florida`s Blood Centers Acquires South Florida Blood Banks II-76 BioStem Takes Over Cryobanks International II-77 FCBS Creates a Niche for itself by designing Cord Blood Stem Cells and Offers Public Donation Option II-77 Pall Signs Sale Agreement with Green Cross for Blood Filters II-77 TCBB Starts Collecting Donations for Cord Blood II-77 Pall Received FDA Clearance to Market New Pall Acrodose™ PL System II-77 CordLife Singapore Receives AABB Accreditation II-78 ITL and ARC Enter into an Agreement for Blood Bank Equipment II-78 NBA and UKT Merge to Form NHSBT II-78 BioMérieux and ExonHit Extend Collaboration to Develop Blood Diagnostics II-78 Wyndgate Signs Agreement with Cameron Hospital II-79 Daxor’s Subsidiary Wins Corporate Blood Banking Contract from Taglich Brothers II-79 Baxter and American Red Cross Enter Into Agreement II-79 CSL Signs Agreement with National Blood Authority II-79 Chiron Finds a South African Partner for Procleix® Tigris® II-79 ThermoGenesis and BHHTI Jointly Market CryoSeal FS II-80 Baxter and Cerus Enter into a Marketing Agreement II-80 Haemonetics Signs Technology Alliance with ZLB Plasma Services II-80 BioTime Collaborates with Summit Pharmaceuticals International Corp. II-80 SurgiLance Bags a Contract from America’s Blood Centers II-80 Florida’s Blood Centers Acquire Lake Park-based South Florida Blood Banks II-80 Global Med Technologies’ Division Signs Agreement with Hospital Partners of America II-81 Radiometer America and Consorta Extend Blood-Gas Products Deal II-81 Baxters ALYX System Wins Medical Design Excellence Award II-81 Terumo Corp. Ups Stake in Blood Bag Venture II-81 Vita 34 International AG Takes over the Holdings of Corcell and Vita 34 II-81 CSL Acquires Aventis Behring II-82 Medsurge Medical Products Corp. Buys Cryo Genomics II-82 Haemonetics’ Acquisition of Harvest Technologies Expands Surgical Blood Salvage Portfolio II-82 Chiron Buys Prion Solutions II-82 Celmed & Gambro Tie up for GvHD Prevention System II-82 Chiron Grants NAT Licenses to LabCorp and German Red Cross II-82 Sekisui Chemical Ventures into Chinese Blood Collection Market II-83 Stratec and Biotest Partner on the Development of a Blood Grouping Analyzer II-83 PRDT, ARC & Maco Pharma in a Strategic Alliance II-83 Pall’s Enhanced Bacterial Detection System to be Marketed by Kawasumi II-83 Baxter and Cerus Rope in Bioone Corp for Marketing Intercept II-84 Chiron Partners with ZymeQuest II-84 Pall Corporation Signs Agreement with Haemonetics Corporation II-84 Haemonetics Corporation & Hemosystem SA in a Marketing Alliance II-84 Chiron’s Armor Strengthened with Infectio’s Rapid Bacterial Detection Licenses II-84 Haemonetics, Braemed and Caster in a Marketing Agreement for Cell Saver® 5 II-85 Haemonetics Obtains Marketing Licenses for Crit Scan® II-85 Lifebank Receives AABB Accreditation II-85 Bayer Divests Plasma Products Business to NPS II-85 ITL Receives FDA Clearance to Market SSK II-86 Chronix Biomedical Files Patent Approval for a New Diagnostic Test II-86 ViaCell’s Selective Amplification™ Program Boosts Cord Blood Banks’ Productivity II-86 CordLife Opens Second Cord Blood Banking Facility Singapore II-86 PharmaStem Inks Multiple Licensing Deals for Cord blood Preservation Technologies II-86 Novation Bags Big Ticket Deals for Blood Products II-86 12. Focus on Select Global Players II-87 Leading Blood Banks II-87 AABB (USA) II-87 America’s Blood Centers (USA) II-87 American Red Cross (USA) II-87 Canadian Blood Services (Canada) II-88 CorCell Companies Inc. (USA) II-88 Cord Blood Registry (USA) II-88 Japan Red Cross (Japan) II-89 Lifebank Corp (Canada) II-89 National Blood Foundation (USA) II-89 New England Cord Blood Bank, Inc. (USA) II-90 New York Blood Center (USA) II-90 VITA 34 AG (Germany) II-90 Leading Players in Blood Bank Technology & Supplies II-91 Beckman Coulter Inc (USA) II-91 Becton Dickinson (USA) II-91 BioMerieux SA (France) II-91 Caridian BCT, Inc (USA) II-91 Chiron (USA) II-92 CSL Behring LLC (USA) II-92 Daxor Corporation (USA) II-93 Fenwal Inc., (USA) II-93 Fresenius SE (Germany) II-93 Gambro AB (Sweden) II-94 Gen-Probe Incorporated (USA) II-94 Haemonetics Corp., (USA) II-94 Hemagen Diagnostics Inc. (USA) II-95 Immucor Inc. (USA) II-95 Kawasumi Laboratories, Inc. (Japan) II-96 Olympus America, Inc. (USA) II-96 PharmaStem Therapeutics, Inc. (USA) II-96 Terumo Corporation (Japan) II-96 ThermoGenesis Corp. (USA) II-97 ZymeQuest, Inc. (USA) II-97 Leading Players in Plasma Fractionation II-97 Baxter International Inc. (USA) II-97 Bio Products Laboratory (UK) II-98 CSL Limited (Australia) II-98 CSL Bioplasma (Australia) II-98 Grifols (Spain) II-98 Kedrion (Italy) II-99 Laboratoire Français du Fractionnement et des Biotechnologies (France) II-99 Octapharma (Switzerland) II-99 Sanquin (The Netherlands) II-100 Talecris Biotherapeutics (USA) II-100 13. Global Market Perspective II-101 Table 17: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) II-101 Table 18: World Long-term Projections for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-102 Table 19: World Historic Review for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) II-103 Table 20: World 15-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) II-104 Table 21: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) II-105 Table 22: World Long-term Projections for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-106 Table 23: World Historic Review for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) II-107 Table 24: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) II-108 Table 25: World Long-term Projections for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-108 Table 26: World Historic Review for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) II-109 Table 27: World 15-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) II-110 Table 28: World 15-Year Perspective for Blood Components and Plasma Products by Product Group - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 1998, 2008 & 2012 II-110 Table 29: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) II-111 Table 30: World Long-term Projections for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-112 Table 31: World Historic Review for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) II-113 Table 32: World 15-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) II-114 Table 33: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) II-115 Table 34: World Long-term Projections for Plasma Fractions by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-116 Table 35: World Historic Review for Plasma Fractions by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) II-117 Table 36: World 15-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) II-118 Table 37: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) II-119 Table 38: World Long-term Projections for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-120 Table 39: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) II-121 Table 40: World 15-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) II-122 III. MARKET 1. The United States III-1 A.Market Analysis III-1 Current and Future Analysis III-1 Market Trends III-1 US Blood Collection & Supply Profile III-1 Blood Group Distribution III-1 Table 41: US Market for Blood Banking and Blood Products: Percentage Break up of Blood Group by Rh Factor (includes corresponding Graph/Chart) III-2 Table 42: Percentage Break up of Rh Blood Types in the US by Racial Group III-2 Blood Donated and Transfused Every Year III-2 Males Form the Major Chunk of Donors III-2 Cost of Blood III-3 SARS Scares: Blood Banks Feel the Heat III-3 Blood and Blood Preparations: Trade Statistics III-3 Table 43: US Blood and Blood Preparations Market (2006 & 2007): Major Import Sources by Country - Germany, UK, Canada, Switzerland, Belgium and Others (In US$ Million) (includes corresponding Graph/Chart) III-3 Table 44: US Blood and Blood Preparations Market (2006 & 2007): Major Export Destinations by Country - Germany, Netherlands, UK, Switzerland, Canada and Others (In US$ Million) (includes corresponding Graph/Chart) III-4 Whole Human Blood: Export-Import Scenario in the Recent Past III-4 Table 45: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Volume Exports by Country - France, Canada, UK, Germany, Japan, Taiwan, Korea, Belgium, Netherlands, Italy, Peru, and Others (includes corresponding Graph/Chart) III-5 Table 46: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Value Exports by Country - France, UK, Germany, Japan, Canada, Belgium, Korea, Peru, Taiwan, Netherlands, Italy, and Others (includes corresponding Graph/Chart) III-6 Table 47: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Volume Imports by Country - Japan, UK, Germany, Indonesia, and Canada (includes corresponding Graph/Chart) III-6 Table 48: US Market for Whole Human Blood 2003 & 2004): Percentage Breakdown of Consumption of Value Imports by Country - Japan, UK, Germany, Indonesia, and Canada (includes corresponding Graph/Chart) III-7 US Blood Components and Plasma Market Analysis in Units III-7 Table 49: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Product Category - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart) III-7 Table 50: US 10-Year Perspective for Blood Components and Plasma by Product Category - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart) III-8 Regulations Control Plasma Collection Industry III-8 Product Launches/Developments III-8 Strategic Corporate Developments III-12 Select Players III-30 Blood Banks III-30 AABB III-30 America’s Blood Centers III-31 American Red Cross III-31 Blood Bank of Alaska III-32 California Cryobank III-32 Family Cord Blood Services Inc. III-32 Community Blood Bank III-33 CorCell Companies Inc. III-33 Cord Blood Registry III-33 National Blood Foundation III-33 New England Cord Blood Bank, Inc. III-34 New York Blood Center III-34 Oklahoma Blood Institute III-34 Blood Bank Technology Developers and Consumables Suppliers III-35 Beckman Coulter Inc. III-35 Becton, Dickinson and Company III-35 Caridian BCT, Inc III-35 Chiron III-36 CSL Behring LLC (USA) III-36 Daxor Corporation III-37 Fenwal Inc., III-37 Gen-Probe Incorporated III-37 Haemonetics Corp., III-38 Hemagen Diagnostics Inc. III-38 Immucor Inc. III-38 Olympus America, Inc. III-39 Pall Corporation III-39 PharmaStem Therapeutics, Inc. III-39 ThermoGenesis Corp. III-40 ViaCell, Inc. III-40 ZymeQuest, Inc. III-40 Major Plasma Fractionators III-41 Baxter International Inc. III-41 Talecris Biotherapeutics III-41 B.Market Analytics III-42 Table 51: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-42 Table 52: US Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-42 Table 53: US Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood and Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-43 Table 54: US 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-43 2. Canada III-44 A.Market Analysis III-44 Current and Future Analysis III-44 Blood Facts III-44 Bleeding Disorders - A Major Threat III-44 The ‘CSA-Z 902-04’ - A Comprehensive Voluntary Blood Safety Standard III-44 Blood and Blood Preparations: Import & Export Scenario III-45 Table 55: Canadian Blood and Blood Preparations Market (2006 & 2007): Major Import Sources by Country - US, The Netherlands, Switzerland, Belgium, Italy and Others (In US$ Million) (includes corresponding Graph/Chart) III-45 Table 56: Canadian Blood and Blood Preparations Market (2006 & 2007): Major Export Destinations by Country - US, France, Chile, Belgium, Germany and Others (In US$ Million) (includes corresponding Graph/Chart) III-45 Product Launches/Developments III-46 Strategic Corporate Developments III-46 Select Players III-48 LifeBank III-48 Canadian Blood Services III-48 The Canadian Hemophilia Society (CHS) III-49 B.Market Analytics III-49 Table 57: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-49 Table 58: Canadian Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood and Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-50 Table 59: Canadian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-50 Table 60: Canadian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-51 3. Japan III-52 A.Market Analysis III-52 Current and Future Analysis III-52 Growing Market for Fresh Frozen Plasma III-52 Strategic Corporate Developments III-52 Select Players III-53 Japan Red Cross III-53 Kawasumi Laboratories, Inc. III-53 Terumo Corporation III-53 B.Market Analytics III-54 Table 61: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-54 Table 62: Japanese Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-55 Table 63: Japanese Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-55 Table 64: Japanese 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-56 4. Europe III-57 A.Market Analysis III-57 Current & Future Analysis III-57 Analysis by Geographic Region III-57 European Blood Banking and Blood Products Market at a Glance (All figures are 2008 estimates & CAGR is for the period 2001-2010) III-57 Analysis by Product Segment III-57 Market Trends and Issues III-58 Legislations on Payment for Donation Restrict Donors III-58 Government’s Check on Healthcare Costs Pressurizes BCT Manufacturers III-58 Purchasing System Witnesses Modifications III-58 EU Nations Marching Towards Self-Sufficiency in Blood and Blood Products III-58 Blood Banking Devices Market III-58 Table 65: European Recent Past, Current & Future Analysis for Blood Banking Devices by Product Segment - Manual Blood Collection, Apheresis, and Autologous Devices Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-59 Table 66: European Long-term Projections Blood Banking Devices by Product Segment - Manual Blood Collection, Apheresis, and Autologous Devices Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-60 Table 67: European 10-Year Perspective for Blood Banking Devices by Product Segment - Manual Blood Collection, Apheresis, and Autologous Devices Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-60 Table 68: European Blood Banking Devices Market (2007): Percentage Breakdown of Value Sales by Geographic Region for France, Germany, Italy, UK, Spain and Rest of Europe (includes corresponding Graph/Chart) III-61 A Snapshot of Health Care Systems Across Select EU Countries III-61 France III-61 Germany III-61 Italy III-61 The UK III-62 Spain III-62 Product Launches/Developments III-62 Strategic Corporate Developments III-63 B.Market Analytics III-67 Table 69: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-67 Table 70: European Long-term Projections for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-68 Table 71: European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-69 Table 72: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-70 Table 73: European Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-71 Table 74: European Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-72 Table 75: European 15-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-73 Table 76: European 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-74 4a. France III-75 A.Market Analysis III-75 Current and Future Analysis III-75 Competitive Scenario III-75 Table 77: Leading Players in the French Blood Banking Devices and Plasma Products Market (2004) - Percentage Breakdown of Revenues for Kedrion, Baxter, and Others (includes corresponding Graph/Chart) III-75 Select Players III-75 BioMérieux SA III-75 Laboratoire Français du Fractionnement et des Biotechnologies III-76 B.Market Analytics III-76 Table 78: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-76 Table 79: French Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-77 Table 80: French Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-77 Table 81: French 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-78 4b. Germany III-79 A.Market Analysis III-79 Current and Future Analysis III-79 Competitive Scenario III-79 Table 82: Leading Players in the German Blood Banking Devices and Plasma Products Market (2004) - Percentage Breakdown of Revenues for ZLB Behring, Baxter, Bayer and Others (includes corresponding Graph/Chart) III-79 Strategic Corporate Developments III-79 Select Players III-80 Fresenius SE III-80 VITA 34 AG III-81 B.Market Analytics III-81 Table 83: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-81 Table 84: German Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-82 Table 85: German Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-82 Table 86: German 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-83 4c. Italy III-84 A.Market Analysis III-84 Current and Future Analysis III-84 Kedrion - A Major Italian Fractionator III-84 B.Market Analytics III-84 Table 87: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group /Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-84 Table 88: Italian Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-85 Table 89: Italian Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-85 Table 90: Italian 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-86 4d. The United Kingdom III-87 A.Market Analysis III-87 Current and Future Analysis III-87 Blood Requirements III-87 Competitive Scenario III-87 Table 91: Leading Players in the UK Blood Banking Devices and Plasma Products Market (2003 & 2004) - Percentage Breakdown of Revenues for Bio Products Laboratory, Baxter, Grifols, and Others (includes corresponding Graph/Chart) III-87 Select Players III-88 Bio Products Laboratory III-88 Surgical Innovations Group Plc III-88 B.Market Analytics III-88 Table 92: UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-88 Table 93: UK Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-89 Table 94: UK Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumable Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-89 Table 95: UK 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-90 4e. Spain III-91 A.Market Analysis III-91 Current and Future Analysis III-91 Competitive Scenario III-91 Table 96: Leading Players in the Spanish Blood Banking Devices and Plasma Products Market (2004) - Percentage Breakdown of Revenues for Baxter, Grifols, ZLB Behring, and Others (includes corresponding Graph/Chart) III-91 Grifols - A Major Player III-91 B.Market Analytics III-92 Table 97: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding graph/Chart) III-92 Table 98: Spanish Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-93 Table 99: Spanish Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-93 Table 100: Spanish 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-94 4f. Russia III-95 Market Analysis III-95 Table 101: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-95 Table 102: Russian Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-96 Table 103: Russian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-96 Table 104: Russian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-97 4g. Rest of Europe III-98 A.Market Analysis III-98 Current and Future Analysis III-98 Denmark - High Participation and Consumption of Blood III-98 Strategic Corporate Developments III-98 Select Players III-99 Gambro AB (Sweden) III-99 Octapharma (Switzerland) III-99 Sanquin (The Netherlands) III-100 B.Market Analytics III-100 Table 105: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-100 Table 106: Rest of Europe Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-101 Table 107: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-102 Table 108: Rest of Europe 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-102 5. Asia-Pacific III-103 A.Market Analysis III-103 Current and Future Analysis III-103 ASEAN - Striding Towards Standardization of Blood Supply III-103 Australia III-103 Role of National Blood Authority III-103 China - A Key Market III-103 Government Wakes Up to Realities III-104 Table 109: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart) III-104 Table 110: Chinese Market for Blood Banking & Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female III-104 Table 111: Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, & 61-70 (includes corresponding Graph/Chart) III-105 India III-105 Healthy Rise in Indian Blood Bank Market III-105 Regularization of Indian Cord Blood Banks III-105 Indonesia III-106 Strategic Corporate Developments III-106 Select Players III-111 CSL Limited (Australia) III-111 CSL Bioplasma (Australia) III-111 Indian Red Cross Society (India) III-112 ITL Limited (Australia) III-112 Rajkot Voluntary Blood Bank (India) III-112 B.Market Analytics III-113 Table 112: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-113 Table 113: Asia-Pacific Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-114 Table 114: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-114 Table 115: Asia-Pacific 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-115 6. Latin America III-116 A.Market Analysis III-116 Current and Future Analysis III-116 Strategic Corporate Development III-116 B.Market Analytics III-117 Table 116: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-117 Table 117: Latin American Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-118 Table 118: Latin American Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-118 Table 119: Latin American 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-119 7. Rest of World III-120 A.Market Analysis III-120 Current and Future Analysis III-120 Strategic Corporate Development III-120 B.Market Analytics III-121 Table 120: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-121 Table 121: Rest of World Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-122 Table 122: Rest of World Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-122 Table 123: Rest of World 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-123 IV. COMPETITIVE LANDSCAPE